Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    October 2017
  1. HEIJNSDIJK EAM, Bangma CH, Borras JM, de Carvalho TM, et al
    Summary statement on screening for prostate cancer in Europe.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31102.
    PubMed     Text format     Abstract available



  2. Retraction: 'Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells' by Nobuyuki Kikuno, Hiroaki Shiina, Shinji Urakami, Ken Kawamoto, Hiroshi Hirata, Yuichiro Tanaka, Shahana Majid, Mikio Ig
    Int J Cancer. 2017;141:1492.
    PubMed     Text format     Abstract available


    August 2017
  3. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    PubMed     Text format     Abstract available


    July 2017
  4. LIN HM, Mahon KL, Weir JM, Mundra PA, et al
    A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer: Authors.
    Int J Cancer. 2017 Jul 25. doi: 10.1002/ijc.30903.
    PubMed     Text format     Abstract available


  5. WANG B, Lo UG, Wu K, Kapur P, et al
    Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30893.
    PubMed     Text format     Abstract available


  6. WANG K, Chen X, Bird VY, Gerke TA, et al
    Association between Age-Related Reductions in Testosterone and Risk of Prostate Cancer - An Analysis of Patients' Data with Prostatic Diseases.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30882.
    PubMed     Text format     Abstract available


  7. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    PubMed     Text format     Abstract available


  8. SCHECHER S, Walter B, Falkenstein M, Macher-Goeppinger S, et al
    Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30864.
    PubMed     Text format     Abstract available


    June 2017
  9. AL-QATATI A, Akrong C, Stevic I, Pantel K, et al
    Plasma microRNA signature is associated with risk stratification in prostate cancer patients.
    Int J Cancer. 2017 Jun 1. doi: 10.1002/ijc.30815.
    PubMed     Text format     Abstract available


    May 2017
  10. DICKERMAN BA, Ahearn TU, Giovannucci E, Stampfer MJ, et al
    Weight change, obesity, and risk of prostate cancer progression among men with clinically localized prostate cancer.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30803.
    PubMed     Text format     Abstract available


  11. WANG Y, Freedman JA, Liu H, Moorman PG, et al
    Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30787.
    PubMed     Text format     Abstract available


    April 2017
  12. POUNIS G, Tabolacci C, Costanzo S, Cordella M, et al
    Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
    Int J Cancer. 2017 Apr 24. doi: 10.1002/ijc.30720.
    PubMed     Text format     Abstract available


  13. PEREZ-CORNAGO A, Travis RC, Appleby PN, Tsilidis KK, et al
    Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Int J Cancer. 2017 Apr 17. doi: 10.1002/ijc.30741.
    PubMed     Text format     Abstract available


  14. ROMAGUERA D, Gracia-Lavedan E, Molinuevo A, de Batlle J, et al
    Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30722.
    PubMed     Text format     Abstract available


    March 2017
  15. KAWADA T
    Dairy intake and prostate cancer survival.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30703.
    PubMed     Text format    


    February 2017
  16. DOWNER MK, Batista JL, Mucci LA, Stampfer MJ, et al
    Dairy intake in relation to prostate cancer survival.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30642.
    PubMed     Text format     Abstract available


    January 2017
  17. SHEN J, Li Z, Song Z, Chen J, et al
    Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30622.
    PubMed     Text format     Abstract available


  18. LUBIK AA, Nouri M, Truong S, Ghaffari M, et al
    Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
    Int J Cancer. 2017;140:358-369.
    PubMed     Text format     Abstract available


  19. HORI S, Wadhwa K, Pisupati V, Zecchini V, et al
    Loss of hSef promotes metastasis through up-regulation of EMT in prostate cancer.
    Int J Cancer. 2017 Jan 10. doi: 10.1002/ijc.30604.
    PubMed     Text format     Abstract available


    December 2016
  20. FARRIS MS, Kopciuk KA, Courneya KS, McGregor SE, et al
    Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30586.
    PubMed     Text format     Abstract available


    November 2016
  21. KUNUTSOR SK, Laukkanen JA
    Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
    Int J Cancer. 2016 Nov 8. doi: 10.1002/ijc.30511.
    PubMed     Text format     Abstract available


    October 2016
  22. HAGGSTROM C, Van Hemelrijck M, Zethelius B, Robinson D, et al
    Prospective study of Type 2 Diabetes Mellitus, anti-diabetic drugs, and risk of prostate cancer.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30480.
    PubMed     Text format     Abstract available


  23. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  24. TAYLOR AE, Martin RM, Geybels MS, Stanford JL, et al
    Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30462.
    PubMed     Text format     Abstract available


  25. NAIR-SHALLIKER V, Yap S, Nunez C, Egger S, et al
    Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Cancer Lifestyle and Evaluation of Risk Study (CLEAR).
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30471.
    PubMed     Text format     Abstract available


    September 2016
  26. BRUNNER C, Davies NM, Martin RM, Eeles R, et al
    Alcohol Consumption and Prostate Cancer Incidence and Progression: A Mendelian Randomization Study.
    Int J Cancer. 2016 Sep 19. doi: 10.1002/ijc.30436.
    PubMed     Text format     Abstract available


  27. WILSON KM, Markt SC, Fang F, Nordenvall C, et al
    Snus use, smoking and survival among prostate cancer patients.
    Int J Cancer. 2016 Sep 1. doi: 10.1002/ijc.30411.
    PubMed     Text format     Abstract available


    August 2016
  28. CRAWLEY D, Garmo H, Rudman S, Stattin P, et al
    Association between duration and type of Androgen Deprivation Therapy and risk of diabetes in men with prostate cancer.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30403.
    PubMed     Text format     Abstract available


    June 2016
  29. RAMBERG H, Grytli HH, Nygard S, Wang W, et al
    PBX3 is a putative biomarker of aggressive Prostate Cancer.
    Int J Cancer. 2016 Jun 7. doi: 10.1002/ijc.30220.
    PubMed     Text format     Abstract available


    May 2016
  30. ZUCCHETTO A, Gini A, Shivappa N, Hebert JR, et al
    Dietary inflammatory index and prostate cancer survival.
    Int J Cancer. 2016 May 31. doi: 10.1002/ijc.30208.
    PubMed     Text format     Abstract available


  31. BONILLA C, Lewis SJ, Rowlands MA, Gaunt TR, et al
    Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30206.
    PubMed     Text format     Abstract available


  32. THAMILSELVAN V, Menon M, Thamilselvan S
    Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants and Akt in preclinical models: New hope for patients with prostate cancer.
    Int J Cancer. 2016 May 20. doi: 10.1002/ijc.30189.
    PubMed     Text format     Abstract available


    April 2016
  33. KENDEL F, Helbig L, Neumann K, Herden J, et al
    Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy.
    Int J Cancer. 2016 Apr 2. doi: 10.1002/ijc.30123.
    PubMed     Text format     Abstract available


    March 2016
  34. BURDELSKI C, Kleinhans S, Kluth M, Hube-Magg C, et al
    Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
    Int J Cancer. 2016;138:1199-206.
    PubMed     Text format     Abstract available


    February 2016
  35. LAPI F, Levi M, Simonetti M, Cancian M, et al
    Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30061.
    PubMed     Text format     Abstract available


  36. BONN SE, Sjolander A, Tillander A, Wiklund F, et al
    Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
    Int J Cancer. 2016 Feb 23. doi: 10.1002/ijc.30052.
    PubMed     Text format     Abstract available


  37. YU L, Toriseva M, Tuomala M, Seikkula H, et al
    Increased expression of fibroblast growth factor 13 (FGF13) in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.
    Int J Cancer. 2016 Feb 17. doi: 10.1002/ijc.30048.
    PubMed     Text format     Abstract available


  38. RYBICKI BA, Rundle A, Kryvenko ON, Mitrache N, et al
    Methylation in Benign Prostate and Risk of Disease Progression in Men Subsequently Diagnosed with Prostate Cancer.
    Int J Cancer. 2016 Feb 10. doi: 10.1002/ijc.30038.
    PubMed     Text format     Abstract available


  39. WANG Y, Jacobs EJ, Newton CC, McCullough ML, et al
    Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study-II Nutrition Cohort.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30027.
    PubMed     Text format     Abstract available


    January 2016
  40. MURTOLA TJ, Karppa EK, Taari K, Talala K, et al
    5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30017.
    PubMed     Text format     Abstract available


  41. SUDHAN DR, Pampo C, Rice L, Siemann DW, et al
    Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29992.
    PubMed     Text format     Abstract available


    December 2015
  42. DYSHLOVOY SA, Menchinskaya ES, Venz S, Rast S, et al
    The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29977.
    PubMed     Text format     Abstract available


  43. DE CARVALHO TM, Heijnsdijk EA, de Koning HJ
    Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29976.
    PubMed     Text format     Abstract available


  44. WU K, Spiegelman D, Hou T, Albanes D, et al
    Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29973.
    PubMed     Text format     Abstract available


  45. THOMSEN FB, Folkvaljon Y, Garmo H, Robinson D, et al
    Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study.
    Int J Cancer. 2015 Dec 14. doi: 10.1002/ijc.29961.
    PubMed     Text format     Abstract available


  46. LYNCH HT, Kosoko-Lasaki O, Leslie SW, Rendell M, et al
    Screening for Familial and Hereditary Prostate Cancer.
    Int J Cancer. 2015 Dec 5. doi: 10.1002/ijc.29949.
    PubMed     Text format     Abstract available


    November 2015
  47. CASTRO NAVA A, Cojoc M, Peitzsch C, Cirillo G, et al
    Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.
    Int J Cancer. 2015;137:2492-503.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: